Differentiated thyroid cancer in a Swedish county – long-term results and quality of life

References

• Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer incidence in five continents, Volumes I to VIII. Lyon: IARC CancerBase No. 7; 2005.
   Google Scholar
• Mazzaferri EL, Kloos RT. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001;86:1447–63.
   PubMed Web of Science ®Google Scholar
• Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med 1998;338:297–306.
   PubMed Web of Science ®Google Scholar
• De Groot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990;71:414–24.
   PubMed Web of Science ®Google Scholar
• Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS, . Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 2007;246:375–84.
   PubMed Web of Science ®Google Scholar
• Pujol P, Daures JP, Nsakala N, Baldet L, Bringer J, Jaffiol C. Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J Clin Endocrinol Metab 1996;81:4318–23.
   PubMed Web of Science ®Google Scholar
• Haigh PI, Urbach DR, Rotstein LE. Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer. Ann Surg Oncol 2005;12:81–9.
   PubMed Web of Science ®Google Scholar
• Lundgren CI, Hall P, Dickman PW, Zedenius J. Influence of surgical and postoperative treatment on survival in differentiated thyroid cancer. Br J Surg 2007;94:571–7.
   PubMed Web of Science ®Google Scholar
• Sullivan M, Karlsson J, Ware J. The Swedish SF-36 Health Survey I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med 1995;41:1349–58.
   PubMed Web of Science ®Google Scholar
• Persson L-O, Karlsson J, Bengtsson C, Steen B, Sullivan M. The Swedish SF-36 Health Survey II. Evaluation of clinical validity; results from population studies of elderly and women in Gothenburg. J Clin Epidemiol 1998;51:1095–103.
   PubMed Web of Science ®Google Scholar
• Sullivan M, Karlsson J. The Swedish SF-36 Health Survey III. Evaluation of criterion-based validity; results from normative population. J Clin Epidemiol 1998;51:1005–113.
   Web of Science ®Google Scholar
• Svensson E. Construction of a single global scale for multi-item assessments of the same variable. Stat Med 2001;20:3831–46.
   PubMed Web of Science ®Google Scholar
• Lundgren CI, Hall P, Dickman PW, Zedenius J. Clinically significant prognostic factors for differentiated thyroid carcinoma: A population-based, nested case-control study. Cancer 2006;106:524–31.
   PubMed Web of Science ®Google Scholar
• Hay ID, McDougall R, Sisson JC. The case against radioio-dine remnant ablation in patients with well differentiated thyroid carcinoma. J Nucl Med 2008;49:1395–7.
   Web of Science ®Google Scholar
• Khanna CM, Dubey YS, Shankar R, Kaur G. Effects of long-term thyroid hormone suppressive treatment of the cardiac functions. Indian Heart J 1997;49:289–92.
   PubMedGoogle Scholar
• Mercuro G, Panzuto MG, Bina A, Leo M, Cabula R, Petrini L, . Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: Effect of individual dose tailoring. J Clin Endocrinol Metabol 2000;85:159–64.
   PubMed Web of Science ®Google Scholar
• Botella-Carretero JI, Gomez-Bueno M, Barrios V, Caballero C, Garcia-Robles R, Sancho J, . Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma. Endocr Relat Cancer 2004;11:345–56.
   PubMed Web of Science ®Google Scholar
• Eroglu A, Berberoglu U, Buruk F, Yildirim E. Completion thyroidectomy for differentiated thyroid carcinoma. J Surg Oncol 1995;59:261–7.
   PubMed Web of Science ®Google Scholar
• Pacini F, Elisei R, Capezzone M, Miccoli P, Molinaro E, Basolo F, . Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low-and high-risk patients. Thyroid 2001;11:877–81.
   PubMed Web of Science ®Google Scholar
• Grigsby PW, Reddy RM, Moley JF, Hall BL. Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment. Surgery 2006;140:1043–9.
   PubMed Web of Science ®Google Scholar
• Hoftijzer HC, . Quality of life in cured patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 2008;93:200–3.
   PubMed Web of Science ®Google Scholar
• Tan LG, Nan L, Thumboo J, Sundram F, Tan LK. Health-related quality of life in thyroid cancer survivors. Laryngoscope 2007;117:507–10.
   PubMed Web of Science ®Google Scholar